| Date | Title | Description | Source |
| 08.03.2024 | CAR T-Cell Therapy Market Set for Healthy Growth after COVID... | CHICAGO, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- Astute Analytica, a leading provider of ... | einpresswi... |
| 08.04.2019 | Startup of the Year nominees share tips for success — cast y... | Seattle startup Crowd Cow accepts the Startup of the Year award at the 2018 GeekWire Awards. (GeekWi... | geekwire.c... |
| 01.02.2018 | Is too much money being invested in oncology? | Oncology is to funding as gravity is to everything else – but is it over the top? Is cancer investme... | medcitynew... |
| 17.01.2018 | Term Sheet — Wednesday, January 17 | 5 Qs WITH A DEALMAKER
Krishna Yeshwant is not your typical VC. In addition to practicing internal me... | fortune.co... |
| 04.01.2018 | Bristol-Myers Squibb Leads $75M Series B For Personal Genome... | Personal Genome Diagnostics Inc. (PGDx) today announced a $75 million Series B financing co-led by n... | citybizlis... |
| 06.12.2017 | Juno inks deals with Eli Lilly, the Hutch as it looks to le... | Juno Therapeutics $JUNO is adding a new approach to its BCMA strategy for multiple myeloma... | endpts.com... |
| 03.03.2017 | Seattle Week in Review: Healing Music Echoes Over ‘Voice Cit... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
It’s still winter, and March, as th... | xconomy.co... |
| 05.12.2016 | Juno gets some badly needed relief after a glimpse of up... | Anxious to turn the page on a deadly series of cerebral edema cases, Juno Therapeutics tod... | endpts.com... |
| 30.11.2016 | Bluebird bio announces positive CAR-T results | Just over four months ago, the FDA put a temporary hold on the same Phase 2 ROCKET trial after two p... | medcitynew... |
| 24.11.2016 | Latest deaths in Juno trial underscore the need for greater ... | The deaths last spring of three patients in a clinical trial of an experimental cancer treatment mad... | statnews.c... |
| 04.10.2016 | Juno CEO: Washington state biotech is ‘going backwards,’ nee... | Juno Therapeutics CEO Hans Bishop speaking at the 2016 GeekWire Summit. Photo by Dan DeLong for Geek... | geekwire.c... |
| 11.09.2016 | AI is for real and intelligent apps is its vehicle according... | Jasper Kuria Contributor
Jasper Kuria is the founder and editor of Capital & Growth.
More posts ... | techcrunch... |
| 08.09.2016 | Stung by patient deaths, a small Juno study points to a Gol... | For Juno, the hunt to find just the right mixture of T cells along with an effective regimen to... | endpts.com... |
| 16.08.2016 | Juno Therapeutics sued on securities fraud allegations follo... | Hans Bishop, Juno Therapeutics CEO, was named as a defendant in the lawsuit.
Juno Therapeutics, a Se... | geekwire.c... |
| 04.08.2016 | Juno posts loss as it amps up R&D spending for cancer tr... | Photo via Juno.
It’s been a busy quarter for Juno Therapeutics with several different immunotherapy ... | geekwire.c... |
| 04.08.2016 | Deaths derail Juno's launch countdown, giving Kite and No... | The FDA’s hold on Juno Therapeutics’ lead CAR-T program, JCAR015, lasted only six days. But th... | endpts.com... |
| 14.07.2016 | And then there were 4: Juno adds another victim in CAR-T ... | Juno’s CAR-T drugs didn’t just kill three people in clinical trials. They actually killed 4, ... | endpts.com... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 18.06.2016 | Revealed: EY names 2016 Entrepreneur of the Year winners for... | Master of ceremonies Jenni Hogan, left, and EY’s Greg Beams, far right, with EY regional Entrepreneu... | geekwire.c... |
| 22.01.2016 | CRISPR gene editing: A commercial timeline | January 2015
Novartis signs two deals with Intellia Therapeutics and Caribou Biosciences to engineer... | medcitynew... |
| 05.01.2016 | These infographics outline Editas’ post-IPO strategy | Here’s an interesting infographic from the prospectus that outlines Editas’ plans for expansion, in ... | medcitynew... |
| 06.12.2015 | Sovereign wealth fund investment in healthcare is on the ris... | “Healthcare is a necessity for people and for the United States, the sector represents a significant... | medcitynew... |
| 24.03.2015 | 30 Startups with the Biggest Funding Rounds in 2014 | In the 2014 fiscal year, $50 billion in venture funding was invested in 5,900 companies – an average... | tech.co/ne... |
| 06.08.2014 | Juno Therapeutics Closes $134M Series B Financing | Juno Therapeutics, Inc., a Seattle, WA-based biotechnology company focused on advancing novel immuno... | finsmes.co... |
| 05.08.2014 | New Series B brings cancer immunotherapy startup Juno Therap... | “What I can tell you,” CEO Hans Bishop said in a phone interview, “is that the funds invested in thi... | medcitynew... |
| 05.08.2014 | Juno Therapeutics Inks $134M Series B Round |
SEATTLE, WA, Biotechnology company focused on bringing forward novel immunotherapies for cancer, t... | vcnewsdail... |
| 25.04.2014 | Juno Therapeutics Closes $176M Series A Funding | Juno Therapeutics, a Seattle, WA-based biotech company focused on developing immunotherapies for can... | finsmes.co... |
| 24.04.2014 | Jeff Bezos-backed Juno Therapeutics closes series A at $176M... | Seattle biotechnology startup Juno Therapeutics, which is developing immunotherapies for cancer, sai... | geekwire.c... |
| 14.01.2014 | Juno Therapeutics Raises $25M in Funding | Juno Therapeutics, a Seattle, WA-based developer of immunotherapies for cancer, raised $25m in fundi... | finsmes.co... |
| 14.01.2014 | Juno Therapeutics Inks Mega $120M Series A |
SEATTLE, WA, New biotechnology company focused on bringing forward novel immunotherapies for cance... | vcnewsdail... |
| 14.01.2014 | Amazon CEO adds second healthcare investment with cancer imm... | Amazon founder Jeff Bezos has taken an interest in cancer immunotherapies. The investment in life sc... | medcitynew... |
| 23.12.2013 | Deals of the Year: The top 28 venture capital investments we... | Venture capital investing in Washington state started out with a whimper in 2013, but it is ending w... | geekwire.c... |
| 05.12.2013 | Juno Therapeutics Raises $120M in Series A Funding | Juno Therapeutics Inc., a Seattle, WA-based clinical stage company that develops cancer immunotherap... | finsmes.co... |
| 03.12.2013 | Cancer research startup Juno Therapeutics raises $120M in ma... | In one of the largest series A venture capital deals this year in the biotechnology sector, Seattle-... | geekwire.c... |
| - | Is too much money being invested in oncology? | Between venture capitalists flush with cash and corporate mergers and acquisitions, money is gushing... | medcitynew... |
| - | Amazon CEO adds second healthcare investment with cancer imm... | Amazon founder Jeff Bezos has taken an interest in cancer immunotherapies. The investment in life sc... | medcitynew... |
| - | These infographics outline Editas’ post-IPO strategy | Cambridge gene editing startup Editas Medicine just filed for a $100 million IPO, marking it the fir... | medcitynew... |
| - | Bluebird bio announces positive CAR-T results | The CAR-T field can rest a little easier, reassured by Wednesday’s positive interim results from blu... | medcitynew... |
| - | Sovereign wealth fund investment in healthcare is on the ris... | In the past couple of years there has been a rise in sovereign wealth funds’ investments in healthca... | medcitynew... |
| - | New Series B brings cancer immunotherapy startup Juno Therap... | The burgeoning cancer immunotherapy space has tons of investors, to be sure, but perhaps no other st... | medcitynew... |
| - | CRISPR gene editing: A commercial timeline | In just three years, CRISPR gene editing has hurtled to the forefront of biological science – with v... | medcitynew... |
